Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 23;18(2):564-567.
doi: 10.5114/aoms/146793. eCollection 2022.

Eosinophilia in a patient with ankylosing spondylitis treated with prolonged adalimumab only

Junhong He  1 , Jing Luo  2 , Qiong Yang  1 , Fangfang Yuan  2
Affiliations

Eosinophilia in a patient with ankylosing spondylitis treated with prolonged adalimumab only

Junhong He et al. Arch Med Sci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Fleischmann RM, Genovese MC, Enejosa JV, et al. Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response. Ann Rheum Dis. 2019;78:1454–62. - PMC - PubMed
    1. LaMattina KC, Goldstein DA. Adalimumab for the treatment of uveitis. Expert Rev Clin Immunol. 2017;13:181–8. - PubMed
    1. Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72:3666–70. - PMC - PubMed
    1. Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS Lett. 2008;582:117–31. - PMC - PubMed
    1. Palladino MA, Bahjat FR, Theodorakis EA, et al. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003;2:736–46. - PubMed